Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intrahepatic Cholangiocarcinoma (Icc)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04782804
What this trial is testing

Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Fudan University 30
Testing effectiveness (Phase 2)UnknownNCT05781958
What this trial is testing

Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shen Feng 64
Testing effectiveness (Phase 2)Looking for participantsNCT05678270
What this trial is testing

ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (ICC)
Beijing InnoCare Pharma Tech Co., Ltd. 70
Not applicableLooking for participantsNCT07640048
What this trial is testing

Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Peking Union Medical College Hospital 90
Large-scale testing (Phase 3)Looking for participantsNCT05342194
What this trial is testing

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Junshi Bioscience Co., Ltd. 480
Not applicableStudy completedNCT07224737
What this trial is testing

Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
City of Hope Medical Center 230
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07632235
What this trial is testing

A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Shanghai 6th People's Hospital 112
Not applicableEnded earlyNCT07043348
What this trial is testing

Streamlining Radioembolization for Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Seoul National University Hospital 1
Large-scale testing (Phase 3)Looking for participantsNCT04353375
What this trial is testing

HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Advanced Intrahepatic CholangiocarcinomaSolid Tumor, Adult
Hutchmed 235
Not applicableUnknownNCT01917370
What this trial is testing

VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway

Who this might be right for
Intrahepatic Cholangiocarcinoma
First Affiliated Hospital, Sun Yat-Sen University 20
Not applicableUnknownNCT02184871
What this trial is testing

Next Generation Sequencing in Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
University of Bologna 45
Testing effectiveness (Phase 2)UnknownNCT05835245
What this trial is testing

Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free)

Who this might be right for
Advanced Intrahepatic Cholangiocarcinoma
Fudan University 30
Testing effectiveness (Phase 2)UnknownNCT03633773
What this trial is testing

Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 9
Testing effectiveness (Phase 2)Study completedNCT05348811
What this trial is testing

HAIC Combined With Donafenib and Sintilimab for Unresectable ICC

Who this might be right for
Cholangiocarcinoma
Zhongda Hospital 25
Testing effectiveness (Phase 2)UnknownNCT04454905
What this trial is testing

Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-sen University 50
Large-scale testing (Phase 3)UnknownNCT03940378
What this trial is testing

Treatment of Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
ICC
The First Affiliated Hospital of Zhengzhou University 152
Testing effectiveness (Phase 2)Study completedNCT07304388
What this trial is testing

HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-sen University 96
Not applicableLooking for participantsNCT07161869
What this trial is testing

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)

Who this might be right for
Hilar CholangiocarcinomaIntrahepatic Cholangiocarcinoma (Icc)Cholangiocarcinoma+3 more
Erasmus Medical Center 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT07646717
What this trial is testing

Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07152769
What this trial is testing

Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC

Who this might be right for
Advanced Intrahepatic Cholangiocarcinoma
Fudan University 104
Next Page